Smad1 + Smad5 Antibody, Cy5 Conjugated

Basic information

Name

Smad1 + Smad5 Antibody, Cy5 Conjugated

size

0.1ml

Catalog number

bs-1619R-Cy5

Price

350 €

Details & buy    

Extended information

Conjugation

Cy5

Modification site

None

Crossreactivity

Human

Additional conjugation

Cy5.5

Tested applications

IF(IHC-P)

French translation

anticorps

Modification

Unmodified

Gene ID number

4090, 4086

Clonality

Polyclonal

Immunogen_range

405-440/465

Concentration

1ug per 1ul

Target Antigen

Smad1 + Smad5

Excitation Emission

625,650nm/670nm

Subcellular location

Cytoplasm, Nucleus

Clone

Polyclonal antibody

Recommended dilutions

IF(IHC-P)(1:50-200)

Category

Conjugated Primary Antibodies

Host Organism

Rabbit (Oryctolagus cuniculus)

Purification method

This antibody was purified via Protein A.

Long name

Smad1 + Smad5 Polyclonal Antibody, Cy5 Conjugated

Specificity

This is a highly specific antibody against Smad1 + Smad5.

Source

KLH conjugated synthetic peptide derived from human Smad 5

Crossreactive species details

Due to limited amount of testing and knowledge, not every possible cross-reactivity is known.

Synonyms

Mothers against decapentaplegic homolog 5; SMAD5; Mothers against decapentaplegic homolog 1; SMAD1

Storage conditions

Keep the antibody in an aqueous buffered solution containing 1% BSA, 50% glycerol and 0.09% sodium azide. Store refrigerated at 2 to 8 degrees Celcius for up to 1 year.

Properties

If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24°C for long term storage and for short term at + 5°C.Cy5 antibodies are excited by the 650-nanometer wave of an argon laser and detected at a 670-nanometer captor.

Antigen background

Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD5 is a receptor-regulated SMAD (R-SMAD). Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression.